# FDA 483 - Molecular PharmaGroup - December 11, 2023

Source: https://www.globalkeysolutions.net/records/483/molecular-pharmagroup/302fe2d2-ed08-4c5a-b31d-245b2174b3ef

> FDA 483 for Molecular PharmaGroup on December 11, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Molecular PharmaGroup
- Inspection Date: 2023-12-11
- Product Type: drugs
- Office Name: FDA District Office — Parsippany, New Jersey

## Related Documents

- [483 - 2025-08-11](https://www.globalkeysolutions.net/records/483/molecular-pharmagroup/1f045f1f-5e0f-485f-8a7a-e3a374653183)
- [483 - 2023-12-11](https://www.globalkeysolutions.net/records/483/molecular-pharmagroup/2049371f-264e-452f-8cc1-f91122004faf)

## Related Officers

- [Director of Clinical Training](https://www.globalkeysolutions.net/people/helen-verdel/f6caf5a8-74f5-4833-bd00-5579b369f4f9)

Company: https://www.globalkeysolutions.net/companies/molecular-pharmagroup/284f8e5d-cf64-49a4-80cb-59cd24428b20

Office: https://www.globalkeysolutions.net/offices/fda-district-office-parsippany-new-jersey/c09c7de9-a2c7-45fc-a42c-8d341c23fc86